Interestingly, the TGF‐β signalling pathway, which is involved in the pathophysiology of IBD in processes such as chronic inflammation, fibrosis and mesenteric fat hyperplasia,78 has been bioinformatically identified to be inhibited by miRNA/mRNA MSC‐EV cargoes using pathway enrichment analyses.79, 87, 88, 89, 90. Here, TGFB1 is linked to inflammatory bowel disease.